INVESTMENT AGREEMENTInvestment Agreement • February 16th, 2017 • Nacht Marius • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 16th, 2017 Company IndustryThis investment Agreement (the “Agreement”) is made and entered into as of December 31, 2016 (the “Effective Date”), by and between BiondVax Pharmaceuticals Ltd., of 14 Einstein Street, Nes-Ziona 74140, Israel (the “Company”), and AngelsInvestments in Hi Tech Ltd., having its business offices at ____________ (“Investor”). The Company and the Investor each are referred herein as a "Party" and together as the "Parties".
Joint Filing Agreement, Dated as of February 16, 2017Joint Filing Agreement • February 16th, 2017 • Nacht Marius • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 16th, 2017 Company IndustryThis Joint Filing Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.